Tissue regeneration in the chronically inflamed tumor environment: Implications for cell fusion driven tumor progression and therapy resistant tumor hybrid cells

International Journal of Molecular Sciences

Volumn 16, Issue 12, 2015, Pages 30362-30381

  Dittmar, Thomas ^a   Zänker, Kurt S ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Aneuploidy; Cancer; Cell fusion; Chromothripsis; Genomic instability; Mutations; Mutator phenotype; Tissue regeneration

Indexed keywords

BUB1 RELATED PROTEIN; BUB3 PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; EPIRUBICIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN MAD2; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR ALPHA;

ANEUPLOIDY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CELL FUSION; DNA DAMAGE; GENE MUTATION; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HYBRID CELL; NEOPLASM; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; TISSUE REGENERATION; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; CLONAL EVOLUTION; GENETICS; PATHOLOGY; PHYSIOLOGY; REGENERATION; TUMOR MICROENVIRONMENT;

ANIMALS; CELL FUSION; CLONAL EVOLUTION; GENOMIC INSTABILITY; HUMANS; HYBRID CELLS; NEOPLASMS; REGENERATION; TUMOR MICROENVIRONMENT;

EID: 84950119418     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161226240     Document Type: Review

References (125)

1. Dittmar, T.; Zänker, K.S. Cell fusion in Health and Disease; Springer: Dordrecht, The Netherlands, 2011; Volume 1, pp. 1-198.
2. Dittmar, T.; Zänker, K.S. Cell fusion in Health and Disease; Springer: Dordrecht, The Netherlands, 2011; Volume 2, pp. 1-202.
3. Dittmar, T.; Rossbach, M. Human pluripotent stem cells in regenerative and personalized medicine. Curr. Mol. Med. 2013, 13, 691-694. [CrossRef] [PubMed].
4. Duelli, D.; Lazebnik, Y. Cell fusion: A hidden enemy? Cancer Cell 2003, 3, 445-448. [CrossRef].
5. Mohr, M.; Zaenker, K.S.; Dittmar, T. Fusion in cancer: An explanatory model for aneuploidy, metastasis formation, and drug resistance. Methods Mol. Biol. 2015, 1313, 21-40. [PubMed].
6. Kozorovitskiy, Y.; Gould, E. Stem cell fusion in the brain. Nat. Cell Biol. 2003, 5, 952-954. [CrossRef] [PubMed].
7. Ogle, B.M.; Cascalho, M.; Platt, J.L. Biological implications of cell fusion. Nat. Rev. Mol. Cell Biol. 2005, 6, 567-575. [CrossRef] [PubMed].
8. Quintana-Bustamante, O.; Alvarez-Barrientos, A.; Kofman, A.V.; Fabregat, I.; Bueren, J.A.; Theise, N.D.; Segovia, J.C. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology 2006, 43, 108-116. [CrossRef] [PubMed].
9. Spees, J.L.; Olson, S.D.; Ylostalo, J.; Lynch, P.J.; Smith, J.; Perry, A.; Peister, A.; Wang, M.Y.; Prockop, D.J. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc. Natl. Acad. Sci. USA 2003, 100, 2397-2402. [CrossRef] [PubMed].
10. Terada, N.; Hamazaki, T.; Oka, M.; Hoki, M.; Mastalerz, D.M.; Nakano, Y.; Meyer, E.M.; Morel, L.; Petersen, B.E.; Scott, E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416, 542-545. [CrossRef] [PubMed].
11. Vassilopoulos, G.; Wang, P.R.; Russell, D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422, 901-904. [CrossRef] [PubMed].
12. Wang, X.; Willenbring, H.; Akkari, Y.; Torimaru, Y.; Foster, M.; Al-Dhalimy, M.; Lagasse, E.; Finegold, M.; Olson, S.; Grompe, M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422, 897-901. [CrossRef] [PubMed].
13. Willenbring, H.; Bailey, A.S.; Foster, M.; Akkari, Y.; Dorrell, C.; Olson, S.; Finegold, M.; Fleming, W.H.; Grompe, M. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat. Med. 2004, 10, 744-748. [CrossRef] [PubMed].
14. Alvarez-Dolado, M.; Pardal, R.; Garcia-Verdugo, J.M.; Fike, J.R.; Lee, H.O.; Pfeffer, K.; Lois, C.; Morrison, S.J.; Alvarez-Buylla, A. Fusion of bone-marrow-derived cells with purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003, 425, 968-973. [CrossRef] [PubMed].
15. Powell, A.E.; Anderson, E.C.; Davies, P.S.; Silk, A.D.; Pelz, C.; Impey, S.; Wong, M.H. Fusion between intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res. 2011, 71, 1497-1505. [CrossRef] [PubMed].
16. Dey, P. Aneuploidy and malignancy: An unsolved equation. J. Clin. Pathol. 2004, 57, 1245-1249. [CrossRef] [PubMed].
17. Sen, S. Aneuploidy and cancer. Curr. Opin. Oncol. 2000, 12, 82-88. [CrossRef] [PubMed].
18. Berndt, B.; Zanker, K.S.; Dittmar, T. Cell fusion is a potent inducer of aneuploidy and drug resistance in tumor cell/normal cell hybrids. Crit. Rev. Oncog. 2013, 18, 97-113. [CrossRef] [PubMed].
19. Lu, X.; Kang, Y. Cell fusion as a hidden force in tumor progression. Cancer Res. 2009, 69, 8536-8539. [CrossRef] [PubMed].
20. Solomon, D.A.; Kim, T.; Diaz-Martinez, L.A.; Fair, J.; Elkahloun, A.G.; Harris, B.T.; Toretsky, J.A.; Rosenberg, S.A.; Shukla, N.; Ladanyi, M.; et al. Mutational inactivation of stag2 causes aneuploidy in human cancer. Science 2011, 333, 1039-1043. [CrossRef] [PubMed].
21. Sotillo, R.; Hernando, E.; Diaz-Rodriguez, E.; Teruya-Feldstein, J.; Cordon-Cardo, C.; Lowe, S.W.; Benezra, R. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007, 11, 9-23. [CrossRef] [PubMed].
22. Weaver, B.A.; Silk, A.D.; Montagna, C.; Verdier-Pinard, P.; Cleveland, D.W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007, 11, 25-36. [CrossRef] [PubMed].
23. Ramakrishnan, M.; Mathur, S.R.; Mukhopadhyay, A. Fusion derived epithelial cancer cells express hematopoietic markers and contribute to stem cell and migratory phenotype in ovarian carcinoma. Cancer Res. 2013, 73, 5360-5370. [CrossRef] [PubMed].
24. Clawson, G.A.; Kimchi, E.; Patrick, S.D.; Xin, P.; Harouaka, R.; Zheng, S.; Berg, A.; Schell, T.; Staveley-O'Carroll, K.F.; Neves, R.I.; et al. Circulating tumor cells in melanoma patients. PLoS ONE 2012, 7, e41052. [CrossRef] [PubMed].
25. Duesberg, P.; Rasnick, D.; Li, R.; Winters, L.; Rausch, C.; Hehlmann, R. How aneuploidy may cause cancer and genetic instability. Anticancer Res. 1999, 19, 4887-4906. [PubMed].
26. Duesberg, P.; Rausch, C.; Rasnick, D.; Hehlmann, R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc. Natl. Acad. Sci. USA 1998, 95, 13692-13697. [CrossRef] [PubMed].
27. Sheltzer, J.M.; Blank, H.M.; Pfau, S.J.; Tange, Y.; George, B.M.; Humpton, T.J.; Brito, I.L.; Hiraoka, Y.; Niwa, O.; Amon, A. Aneuploidy drives genomic instability in yeast. Science 2011, 333, 1026-1030. [CrossRef] [PubMed].
28. Wilkens, L.; Flemming, P.; Gebel, M.; Bleck, J.; Terkamp, C.; Wingen, L.; Kreipe, H.; Schlegelberger, B. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 2004, 101, 1309-1314. [CrossRef] [PubMed].
29. Chakraborty, A.; Lazova, R.; Davies, S.; Backvall, H.; Ponten, F.; Brash, D.; Pawelek, J. Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant. 2004, 34, 183-186. [CrossRef] [PubMed].
30. Yilmaz, Y.; Lazova, R.; Qumsiyeh, M.; Cooper, D.; Pawelek, J. Donor y chromosome in renal carcinoma cells of a female bmt recipient: Visualization of putative bmt-tumor hybrids by fish. Bone Marrow Transplant. 2005, 35, 1021-1024. [CrossRef] [PubMed].
31. Andersen, T.L.; Boissy, P.; Sondergaard, T.E.; Kupisiewicz, K.; Plesner, T.; Rasmussen, T.; Haaber, J.; Kolvraa, S.; Delaisse, J.M. Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: A new type of cancer-host partnership? J. Pathol. 2007, 211, 10-17. [CrossRef] [PubMed].
32. Clawson, G.A.; Matters, G.L.; Xin, P.; Imamura-Kawasawa, Y.; Du, Z.; Thiboutot, D.M.; Helm, K.F.; Neves, R.I.; Abraham, T. Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS ONE 2015, 10, e0134320. [CrossRef] [PubMed].
33. Shabo, I.; Olsson, H.; Stal, O.; Svanvik, J. Breast cancer expression of dap12 is associated with skeletal and liver metastases and poor survival. Clin. Breast Cancer 2013, 13, 371-377. [CrossRef] [PubMed].
34. Shabo, I.; Olsson, H.; Sun, X.F.; Svanvik, J. Expression of the macrophage antigen cd163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int. J. Cancer 2009, 125, 1826-1831. [CrossRef] [PubMed].
35. Shabo, I.; Stal, O.; Olsson, H.; Dore, S.; Svanvik, J. Breast cancer expression of cd163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int. J. Cancer 2008, 123, 780-786. [CrossRef] [PubMed].
36. Shabo, I.; Svanvik, J. Expression of macrophage antigens by tumor cells. Adv. Exp. Med. Biol. 2011, 714, 141-150. [PubMed].
37. Lazova, R.; Laberge, G.S.; Duvall, E.; Spoelstra, N.; Klump, V.; Sznol, M.; Cooper, D.; Spritz, R.A.; Chang, J.T.; Pawelek, J.M. A melanoma brain metastasis with a donor-patient hybrid genome following bone marrow transplantation: First evidence for fusion in human cancer. PLoS ONE 2013, 8, e66731. [CrossRef] [PubMed].
38. Aichel, O. Über zellverschmelzung mit quantitativ abnormer chromosomenverteilung als ursache der geschwulstbildung. In Vorträge und aufsätze über entwicklungsmechanik der organismen; Roux, W., Ed.; Wilhelm Engelmann: Leipzig, Germany, 1911; pp. 1-115.
39. Clawson, G.A. Cancer. Fusion for moving. Science 2013, 342, 699-700. [CrossRef] [PubMed].
40. Parris, G.E. Historical perspective of cell-cell fusion in cancer initiation and progression. Crit. Rev. Oncog. 2013, 18, 1-18. [CrossRef] [PubMed].
41. Camargo, F.D.; Chambers, S.M.; Goodell, M.A. Stem cell plasticity: From transdifferentiation to macrophage fusion. Cell Prolif. 2004, 37, 55-65. [CrossRef] [PubMed].
42. Ferrand, J.; Noel, D.; Lehours, P.; Prochazkova-Carlotti, M.; Chambonnier, L.; Menard, A.; Megraud, F.; Varon, C. Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS ONE 2011, 6, e19569. [CrossRef] [PubMed].
43. Rizvi, A.Z.; Swain, J.R.; Davies, P.S.; Bailey, A.S.; Decker, A.D.;Willenbring, H.; Grompe, M.; Fleming,W.H.; Wong, M.H. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc. Natl. Acad. Sci. USA 2006, 103, 6321-6325. [CrossRef] [PubMed].
44. Wang, Y.; Fan, H.; Zhou, B.; Ju, Z.; Yu, L.; Guo, L.; Han, J.; Lu, S. Fusion of human umbilical cord mesenchymal stem cells with esophageal cells. Int. J. Oncol. 2012, 40, 370-377. [PubMed].
45. Davies, P.S.; Powell, A.E.; Swain, J.R.; Wong, M.H. Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS ONE 2009, 4, e6530. [CrossRef] [PubMed].
46. Johansson, C.B.; Youssef, S.; Koleckar, K.; Holbrook, C.; Doyonnas, R.; Corbel, S.Y.; Steinman, L.; Rossi, F.M.; Blau, H.M. Extensive fusion of haematopoietic cells with purkinje neurons in response to chronic inflammation. Nat. Cell Biol. 2008, 10, 575-583. [CrossRef] [PubMed].
47. Mohr, M.; Tosun, S.; Arnold, W.H.; Edenhofer, F.; Zanker, K.S.; Dittmar, T. Quantification of cell fusion events human breast cancer cells and breast epithelial cells using a cre-loxp-based double fluorescence reporter system. Cell. Mol. Life Sci. 2015, 72, 3769-3782. [CrossRef] [PubMed].
48. Song, K.; Zhu, F.; Zhang, H.Z.; Shang, Z.J. Tumor necrosis factor-alpha enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via vcam-1/vla-4 pathway. Exp. Cell Res. 2012, 318, 1707-1715. [CrossRef] [PubMed].
49. Arwert, E.N.; Hoste, E.; Watt, F.M. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 2012, 12, 170-180. [CrossRef] [PubMed].
50. Van Loon, S.L.M.; Smits, A.I.P.M.; Driessen-Mol, A.; Baaijens, F.P.T.; Bouten, C.V.C. The immune response in in situ tissue engineering of aortic heart valves. In Calcific Aortic Valve Disease; Aikawa, E., Ed.; InTech: West Palm Beach, FL, USA, 2013; Volume 8, pp. 207-245.
51. Balkwill, F.; Mantovani, A. Inflammation and cancer: Back to virchow? Lancet 2001, 357, 539-545. [CrossRef].
52. Coussens, L.M.;Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867. [CrossRef] [PubMed].
53. Dvorak, H.F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 1986, 315, 1650-1659. [PubMed].
54. Madar, S.; Goldstein, I.; Rotter, V. 'Cancer associated fibroblasts'-More than meets the eye. Trends Mol. Med. 2013, 19, 447-453. [CrossRef] [PubMed].
55. Mantovani, A.; Bottazzi, B.; Colotta, F.; Sozzani, S.; Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today 1992, 13, 265-270. [CrossRef].
56. Mantovani, A.; Sica, A.; Locati, M. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 2007, 37, 14-16. [CrossRef] [PubMed].
57. Noubissi, F.K.; Harkness, T.; Alexander, C.M.; Ogle, B.M. Apoptosis-induced cancer cell fusion: A mechanism of breast cancer metastasis. FASEB J. 2015, 29, 4036-4045. [CrossRef] [PubMed].
58. Dittmar, T.; Nagler, C.; Niggemann, B.; Zänker, K.S. The dark side of stem cells: Triggering cancer progression by cell fusion. Curr. Mol. Med. 2013, 13, 735-750. [CrossRef] [PubMed].
59. Loeb, L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991, 51, 3075-3079. [PubMed].
60. Pihan, G.; Doxsey, S.J. Mutations and aneuploidy: Co-conspirators in cancer? Cancer Cell 2003, 4, 89-94. [CrossRef].
61. Boveri, T. On multipolar mitosis as a means of analysis of the cell nucleus. In Foundations of Experimental Embryology; Willier, B.H., Oppenheimer, J.M., Eds.; Prentice Hall: New York, NY, USA, Volume 2, 1902; pp. 74-97.
62. Duesberg, P. Chromosomal chaos and cancer. Sci. Am. 2007, 296, 52-59. [CrossRef] [PubMed].
63. Loeb, K.R.; Loeb, L.A. Significance of multiple mutations in cancer. Carcinogenesis 2000, 21, 379-385. [CrossRef] [PubMed].
64. Fox, E.J.; Prindle, M.J.; Loeb, L.A. Do mutator mutations fuel tumorigenesis? Cancer Metastasis Rev. 2013, 32, 353-361. [CrossRef] [PubMed].
65. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674. [CrossRef] [PubMed].
66. Loeb, L.A. Mutator phenotype in cancer: Origin and consequences. Semin. Cancer Biol. 2010, 20, 279-280. [CrossRef] [PubMed].
67. Li, R.; Sonik, A.; Stindl, R.; Rasnick, D.; Duesberg, P. Aneuploidy versus gene mutation hypothesis of cancer: Recent study claims mutation, but is found to support aneuploidy. Proc. Natl. Acad. Sci. USA 2000, 97, 3236-3241. [CrossRef] [PubMed].
68. Duesberg, P.; Li, R.; Fabarius, A.; Hehlmann, R. Aneuploidy and cancer: From correlation to causation. Contrib. Microbiol. 2006, 13, 16-44. [PubMed].
69. Bhatia, B.; Schneider-Broussard, R.; Calhoun, T.; Tang, S.; Zhou, J.; Schroeder, L.; Shen, J.; Multani, A.S.; Pathak, S.; Chang, S.; et al. Replicative senescence and cell fusion-mediated immortalization and tumorigenic transformation of normal human prostate (nhp) epithelial cells: Implications in prostate tumorigenesis and tumor heterogeneity. Proc. Am. Assoc. Cancer Res. 2005, 46, 2060.
70. Bjerkvig, R.; Tysnes, B.B.; Aboody, K.S.; Najbauer, J.; Terzis, A.J. Opinion: The origin of the cancer stem cell: Current controversies and new insights. Nat. Rev. Cancer 2005, 5, 899-904. [CrossRef] [PubMed].
71. Zhou, X.; Merchak, K.; Lee, W.; Grande, J.P.; Cascalho, M.; Platt, J.L. Cell fusion connects oncogenesis with tumor evolution. Am. J. Pathol. 2015, 185, 2049-2060. [CrossRef] [PubMed].
72. Hatch, E.M.; Hetzer, M.W. Chromothripsis. Curr. Biol. 2015, 25, R397-R399. [CrossRef] [PubMed].
73. Goldenberg, D.M.; Pavia, R.A.; Tsao, M.C. In vivo hybridisation of human tumour and normal hamster cells. Nature 1974, 250, 649-651. [CrossRef] [PubMed].
74. Jacobsen, B.M.; Harrell, J.C.; Jedlicka, P.; Borges, V.F.; Varella-Garcia, M.; Horwitz, K.B. Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res. 2006, 66, 8274-8279. [CrossRef] [PubMed].
75. Kaur, E.; Rajendra, J.; Jadhav, S.; Shridhar, E.; Goda, J.S.; Moiyadi, A.; Dutt, S. Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence. Carcinogenesis 2015, 36, 685-695. [CrossRef] [PubMed].
76. Duncan, A.W.; Hickey, R.D.; Paulk, N.K.; Culberson, A.J.; Olson, S.B.; Finegold, M.J.; Grompe, M. Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genet. 2009, 5, e1000385. [CrossRef] [PubMed].
77. Duncan, A.W.; Taylor, M.H.; Hickey, R.D.; Hanlon Newell, A.E.; Lenzi, M.L.; Olson, S.B.; Finegold, M.J.; Grompe, M. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010, 467, 707-710. [CrossRef] [PubMed].
78. Hernando, E.; Nahle, Z.; Juan, G.; Diaz-Rodriguez, E.; Alaminos, M.; Hemann, M.; Michel, L.; Mittal, V.; Gerald, W.; Benezra, R.; et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 2004, 430, 797-802. [CrossRef] [PubMed].
79. Van't Veer, L.J.; Dai, H.; van de Vijver, M.J.; He, Y.D.; Hart, A.A.; Mao, M.; Peterse, H.L.; van der Kooy, K.; Marton, M.J.; Witteveen, A.T.; et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415, 530-536.
80. Schuyler, S.C.; Wu, Y.F.; Kuan, V.J. The mad1-mad2 balancing act-A damaged spindle checkpoint in chromosome instability and cancer. J. Cell Sci. 2012, 125, 4197-4206. [CrossRef] [PubMed].
81. Baker, D.J.; Jeganathan, K.B.; Cameron, J.D.; Thompson, M.; Juneja, S.; Kopecka, A.; Kumar, R.; Jenkins, R.B.; de Groen, P.C.; Roche, P.; et al. Bubr1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat. Genet. 2004, 36, 744-749. [CrossRef] [PubMed].
82. Shichiri, M.; Yoshinaga, K.; Hisatomi, H.; Sugihara, K.; Hirata, Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hbub1 and hbubr1 and their relationship to survival. Cancer Res. 2002, 62, 13-17. [PubMed].
83. Babu, J.R.; Jeganathan, K.B.; Baker, D.J.; Wu, X.; Kang-Decker, N.; van Deursen, J.M. Rae1 is an essential mitotic checkpoint regulator that cooperates with bub3 to prevent chromosome missegregation. J. Cell Biol. 2003, 160, 341-353. [CrossRef] [PubMed].
84. Hanks, S.; Coleman, K.; Reid, S.; Plaja, A.; Firth, H.; Fitzpatrick, D.; Kidd, A.; Mehes, K.; Nash, R.; Robin, N.; et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in bub1b. Nat. Genet. 2004, 36, 1159-1161. [CrossRef] [PubMed].
85. Cahill, D.P.; Lengauer, C.; Yu, J.; Riggins, G.J.; Willson, J.K.; Markowitz, S.D.; Kinzler, K.W.; Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392, 300-303. [PubMed].
86. Fabarius, A.; Hehlmann, R.; Duesberg, P.H. Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. Cancer Genet. Cytogenet. 2003, 143, 59-72. [CrossRef].
87. Crasta, K.; Ganem, N.J.; Dagher, R.; Lantermann, A.B.; Ivanova, E.V.; Pan, Y.; Nezi, L.; Protopopov, A.; Chowdhury, D.; Pellman, D. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012, 482, 53-58. [CrossRef] [PubMed].
88. Janssen, A.; van der Burg, M.; Szuhai, K.; Kops, G.J.; Medema, R.H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 2011, 333, 1895-1898. [CrossRef] [PubMed].
89. Zhou, X.; Platt, J.L. Molecular and cellular mechanisms of mammalian cell fusion. Adv. Exp. Med. Biol. 2011, 713, 33-64. [PubMed].
90. Huppertz, B.; Gauster, M. Trophoblast fusion. Adv. Exp. Med. Biol. 2011, 713, 81-95. [PubMed].
91. Aguilar, P.S.; Baylies, M.K.; Fleissner, A.; Helming, L.; Inoue, N.; Podbilewicz, B.; Wang, H.; Wong, M. Genetic basis of cell-cell fusion mechanisms. Trends Genet. 2013, 29, 427-437. [CrossRef] [PubMed].
92. Yu, H.; Liu, T.; Zhao, Z.; Chen, Y.; Zeng, J.; Liu, S.; Zhu, F. Mutations in 31-long terminal repeat of herv-w family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-myb. Oncogene 2014, 33, 3947-3958. [CrossRef] [PubMed].
93. Bjerregaard, B.; Holck, S.; Christensen, I.J.; Larsson, L.I. Syncytin is involved in breast cancer-endothelial cell fusions. Cell. Mol. Life Sci. 2006, 63, 1906-1911. [CrossRef] [PubMed].
94. Abdelmagid, S.M.; Sondag, G.R.; Moussa, F.M.; Belcher, J.Y.; Yu, B.; Stinnett, H.; Novak, K.; Mbimba, T.; Khol, M.; Hankenson, K.D.; et al. Mutation in osteoactivin promotes receptor activator of nfkappab ligand (rankl)-mediated osteoclast differentiation and survival but inhibits osteoclast function. J. Biol. Chem. 2015, 290, 20128-20146. [CrossRef] [PubMed].
95. Silvestris, F.; Ciavarella, S.; Strippoli, S.; Dammacco, F. Cell fusion and hyperactive osteoclastogenesis in multiple myeloma. Adv. Exp. Med. Biol. 2011, 714, 113-128. [PubMed].
96. Malassine, A.; Pidoux, G.; Gerbaud, P.; Frendo, J.L.; Evain-Brion, D. Human trophoblast in trisomy 21: A model for cell-cell fusion dynamic investigation. Adv. Exp. Med. Biol. 2011, 714, 103-112. [PubMed].
97. Berndt, B.; Haverkampf, S.; Reith, G.; Keil, S.; Niggemann, B.; Zanker, K.S.; Dittmar, T. Fusion of ccl21 non-migratory active breast epithelial and breast cancer cells give rise to ccl21 migratory active tumor hybrid cell lines. PLoS ONE 2013, 8, e63711. [CrossRef] [PubMed].
98. Wang, R.; Sun, X.; Wang, C.Y.; Hu, P.; Chu, C.Y.; Liu, S.; Zhau, H.E.; Chung, L.W. Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression. PLoS ONE 2012, 7, e42653. [CrossRef] [PubMed].
99. Zeng, C.; Zhang, Y.; Park, S.C.; Eun, J.R.; Nguyen, N.T.; Tschudy-Seney, B.; Jung, Y.J.; Theise, N.D.; Zern, M.A.; Duan, Y. Cd34 liver cancer stem cells were formed by fusion of hepatobiliary stem/progenitor cells with hematopoietic precursor-derived myeloid intermediates. Stem Cells Dev. 2015, 24, 2467-2478. [CrossRef] [PubMed].
100. Carloni, V.; Mazzocca, A.; Mello, T.; Galli, A.; Capaccioli, S. Cell fusion promotes chemoresistance in metastatic colon carcinoma. Oncogene 2013, 32, 2649-2660. [CrossRef] [PubMed].
101. Duelli, D.M.; Padilla-Nash, H.M.; Berman, D.; Murphy, K.M.; Ried, T.; Lazebnik, Y. A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr. Biol. 2007, 17, 431-437. [CrossRef] [PubMed].
102. Martin-Padura, I.; Marighetti, P.; Gregato, G.; Agliano, A.; Malazzi, O.; Mancuso, P.; Pruneri, G.; Viale, A.; Bertolini, F. Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential. Neoplasia 2012, 14, 1057-1066. [CrossRef] [PubMed].
103. Miller, F.R.; Mohamed, A.N.; McEachern, D. Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res. 1989, 49, 4316-4321. [PubMed].
104. Pawelek, J.M.; Chakraborty, A.K. Fusion of tumour cells with bone marrow-derived cells: A unifying explanation for metastasis. Nat. Rev. Cancer 2008, 8, 377-386. [CrossRef] [PubMed].
105. Wakeling, W.F.; Greetham, J.; Bennett, D.C. Efficient spontaneous fusion between some co-cultured cells, especially murine melanoma cells. Cell Biol. Int. 1994, 18, 207-210. [CrossRef] [PubMed].
106. Yan, Y.; Hsu, Y.; He, X.; Lu, N.; Wei, W.; Zhang, Z.; Zhu, L. Evidence of cell fusion in carcinogen-induced mice gastric carcinoma. Tumour Biol. 2015, 36, 5089-5094. [CrossRef] [PubMed].
107. Rachkovsky, M.; Sodi, S.; Chakraborty, A.; Avissar, Y.; Bolognia, J.; McNiff, J.M.; Platt, J.; Bermudes, D.; Pawelek, J. Melanoma macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis 1998, 16, 299-312. [CrossRef] [PubMed].
108. Dittmar, T.; Schwitalla, S.; Seidel, J.; Haverkampf, S.; Reith, G.; Meyer-Staeckling, S.; Brandt, B.H.; Niggemann, B.; Zanker, K.S. Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin. Exp. Metastasis 2011, 28, 75-90. [CrossRef] [PubMed].
109. Fortuna, M.B.; Dewey, M.J.; Furmanski, P. Cell fusion in tumor development and progression: Occurrence of cell fusion in primary methylcholanthrene-induced tumorigenesis. Int. J. Cancer 1989, 44, 731-737. [CrossRef] [PubMed].
110. Miller, F.R.; McInerney, D.; Rogers, C.; Miller, B.E. Spontaneous fusion between metastatic mammary tumor subpopulations. J. Cell. Biochem. 1988, 36, 129-136. [CrossRef] [PubMed].
111. Duesberg, P.; Stindl, R.; Hehlmann, R. Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc. Natl. Acad. Sci. USA 2000, 19, 14295-14300. [CrossRef] [PubMed].
112. Yan, B.; Wang, J.; Liu, L. Chemotherapy promotes tumour cell hybridization in vivo. Tumour Biol. 2015, 6, 1-6. [CrossRef] [PubMed].
113. Blagosklonny, M.V. Why therapeutic response may not prolong the life of a cancer patient: Selection for oncogenic resistance. Cell Cycle 2005, 4, 1693-1698. [CrossRef] [PubMed].
114. Dittmar, T.; Nagler, C.; Schwitalla, S.; Reith, G.; Niggemann, B.; Zanker, K.S. Recurrence cancer stem cells-made by cell fusion? Med. Hypotheses 2009, 73, 542-547. [CrossRef] [PubMed].
115. Clevers, H. The cancer stem cell: Premises, promises and challenges. Nat. Med. 2011, 17, 313-319. [CrossRef] [PubMed].
116. Kreso, A.; Dick, J.E. Evolution of the cancer stem cell model. Cell Stem Cell 2014, 14, 275-291. [CrossRef] [PubMed].
117. Huff, C.A.; Matsui,W.; Smith, B.D.; Jones, R.J. The paradox of response and survival in cancer therapeutics. Blood 2006, 107, 431-434. [CrossRef] [PubMed].
118. Jones, R.J.; Matsui, W.H.; Smith, B.D. Cancer stem cells: Are we missing the target? J. Natl. Cancer Inst. 2004, 96, 583-585. [CrossRef] [PubMed].
119. Notta, F.; Mullighan, C.G.; Wang, J.C.; Poeppl, A.; Doulatov, S.; Phillips, L.A.; Ma, J.; Minden, M.D.; Downing, J.R.; Dick, J.E. Evolution of human bcr-abl1 lymphoblastic leukaemia-initiating cells. Nature 2011, 469, 362-367. [CrossRef] [PubMed].
120. Wright, M.H.; Calcagno, A.M.; Salcido, C.D.; Carlson, M.D.; Ambudkar, S.V.; Varticovski, L. Brca1 breast tumors contain distinct cd44+/cd24-and cd133+ cells with cancer stem cell characteristics. Breast Cancer Res. 2008, 10, R10. [CrossRef] [PubMed].
121. Alison, M.R.; Islam, S.;Wright, N.A. Stem cells in cancer: Instigators and propagators? J. Cell Sci. 2010, 123, 2357-2368. [CrossRef] [PubMed].
122. Mullighan, C.G.; Phillips, L.A.; Su, X.; Ma, J.; Miller, C.B.; Shurtleff, S.A.; Downing, J.R. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 2008, 322, 1377-1380. [CrossRef] [PubMed].
123. Skinner, A.M.; Grompe, M.; Kurre, P. Intra-hematopoietic cell fusion as a source of somatic variation in the hematopoietic system. J. Cell Sci. 2012, 125, 2837-2843. [CrossRef] [PubMed].
124. Verfaillie, C.M. Hematopoietic stem cells for transplantation. Nat. Immunol. 2002, 3, 314-317. [CrossRef] [PubMed].
125. Murch, A.R.; Grounds, M.D.; Marshall, C.A.; Papadimitriou, J.M. Direct evidence that inflammatory multinucleate giant cells form by fusion. J. Pathol. 1982, 137, 177-180. [CrossRef] [PubMed].